A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients

BACKGROUND: Despite aggressive treatment, more than 90% of glioblastoma (GBM) patients experience recurrences. GBM response to therapy is currently assessed by imaging techniques and tissue biopsy. However, difficulties with these methods may cause misinterpretation of treatment outcomes. Currently,...

Descripción completa

Detalles Bibliográficos
Autores principales: Muller Bark, Juliana, Karpe, Avinash V., Doecke, James D., Leo, Paul, Jeffree, Rosalind L., Chua, Benjamin, Day, Bryan W., Beale, David J., Punyadeera, Chamindie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242862/
https://www.ncbi.nlm.nih.gov/pubmed/37031458
http://dx.doi.org/10.1002/cam4.5857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242862/
https://www.ncbi.nlm.nih.gov/pubmed/37031458
http://dx.doi.org/10.1002/cam4.5857

Ejemplares similares